At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Adaptive servo-ventilation (ASV) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Adaptive Servoventilation (ASV) in Patients With Central Sleep Apnea Due to Chronic Opioid Use
In Brief
A clinical study evaluating Adaptive servo-ventilation (ASV) and Bi-Level PAP for Obstructive Sleep Apnea and 2 related conditions. Completed, enrolled 21 participants across 1 site.
Detailed Summary
Prospective, randomized, blinded, cross-over study assessing the effectiveness of adaptive servo-ventilation (ASV) in treating patients who have obstructive sleep apnea (OSA) complicated by central sleep apnea (CSA) due to the chronic use of opioid medications
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2011
First PostedOct 2011
Primary CompletionNov 2012
Study CompletionDec 2012
TodayJul 2026
First PostedOct 28, 2011
Enrollment StartSep 1, 2011
Primary CompletionNov 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.7 years ago
Interventions
Adaptive servo-ventilation (ASV)device
Adaptive servo-ventilation (ASV) is a form of positive airway pressure (PAP) that is delivered based on the needs of the individual.
Bi-Level PAPdevice
Bi-Level PAP delivers therapy at 2 pressures IPAP and EPAP that are fixed.